Low-Dose Aspirin Halves Bowel Cancer Risk

A major British study has found that taking a daily low-dose aspirin (75-100mg) can halve the risk of developing bowel cancer in people with Lynch syndrome, a genetic disorder that greatly increases cancer risk. Despite NHS recommendations, only about a quarter of those with Lynch syndrome take aspirin, often due to concerns about side effects, but the research shows lower doses are both effective and safer. Separate expert guidance stresses that increasing fibre intake from foods such as nuts, berries, peas, and legumes can significantly reduce bowel cancer risk, with fibre deficiency linked to 28% of cases in the UK. Consuming superfoods like broccoli, blueberries, and tomatoes also offers protective benefits by reducing inflammation and supporting immune function. These findings highlight the combined importance of medication and dietary changes in lowering cancer risk for high-risk individuals. Updated clinical guidelines further emphasize timely and evidence-based management of bowel diseases to support prevention.